Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Phase 2 crawled date : 2021 - 06 - 22 save search
Keros Therapeutics Announces Preliminary Results from its Phase 2 Clinical Trial Evaluating KER-050 in Patients with Myelodysplastic Syndromes
Published: 2021-06-22 (Crawled : 22:00) - biospace.com/
KROS | $58.345 -1.03% -1.04% 350K
|
Health Technology
|
| O: -0.45%
H: 0.34%
C: -1.13%
phase 2 results trial syndros
ADC Therapeutics Announces Encouraging Interim Results from Pivotal Phase 2 Clinical Trial of Camidanlumab Tesirine (Cami) Presented at the 16th Annual International Conference on Malignant Lymphoma
Published: 2021-06-22 (Crawled : 15:00) - biospace.com/
ADCT | $4.72 -0.84% 0.0% 320K
|
Health Technology
|
| O: 0.04%
H: 1.62%
C: -1.58%
GMAB | $28.72 1.38% 1.36% 360K
|
Health Technology
|
| O: 0.09%
H: 0.63%
C: 0.53%
phase 2 results trial conference
JanOne Selects Regulatory Partner for Phase 2b Trial as Investigational Plan is Prepared for FDA Filing
Published: 2021-06-22 (Crawled : 14:00) - prnewswire.com
JAN | $3.94 6.49% 6.09% 160K
|
Industrial Services
|
| O: 2.49%
H: 41.97%
C: 7.63%
fda phase 2 phase 2b trial
Sorrento Announces Phase 2 Abivertinib Clinical Studies Have Completed Patient Enrollment in USA and Brazil with Top-Line Clinical Data Expected End of 3Q21
Published: 2021-06-22 (Crawled : 14:00) - biospace.com/
SRNE | $0.024 -8.85% 57K
|
Health Technology
|
| O: -0.92%
H: 4.99%
C: 3.72%
phase 2 brazil topline enroll
Dicerna Initiates Patient Dosing in ESTRELLA Phase 2 Clinical Trial of Belcesiran for the Treatment of Alpha-1 Antitrypsin Deficiency-Associated Liver Disease
Published: 2021-06-22 (Crawled : 12:15) - biospace.com/
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.39%
H: 0.27%
C: -0.21%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.02%
H: 0.44%
C: -0.53%
ALNY | $144.315 -0.58% -0.59% 700K
|
Health Technology
|
| O: 0.08%
H: 1.01%
C: 0.9%
disease liver disease treatment phase 2 liver trial
Histogen and Amerimmune Announce Positive Top-Line Study Results from its Phase 1 Study of Emricasan in Mild Symptomatic COVID-19 Patients
Published: 2021-06-22 (Crawled : 12:15) - globenewswire.com
HSTO 1 d | $0.5 67.46% 530
|
Health Technology
|
| O: 6.65%
H: 21.78%
C: 8.91%
covid phase 1 positive results phase 2 topline
Sanofi and Translate Bio Initiate Phase 1 Clinical Trial of mRNA Influenza Vaccine
Published: 2021-06-22 (Crawled : 06:00) - globenewswire.com
TBIO | $0.302 -8.76% -9.6% 160K
|
Health Technology
|
| O: 0.0%
H: 10.57%
C: 10.25%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.57%
H: 0.25%
C: -0.04%
phase 1 vaccine influenza trial phase 2 phase 3
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.